Trial record 6 of 6 for:    Open Studies | "Carbon Monoxide Poisoning"

End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning

This study is currently recruiting participants.
Verified December 2013 by Minneapolis Medical Research Foundation
Sponsor:
Information provided by (Responsible Party):
Minneapolis Medical Research Foundation
ClinicalTrials.gov Identifier:
NCT01859156
First received: May 8, 2013
Last updated: December 19, 2013
Last verified: December 2013
  Purpose

The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.


Condition
Carbon Monoxide Exposure

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide

Resource links provided by NLM:


Further study details as provided by Minneapolis Medical Research Foundation:

Primary Outcome Measures:
  • EtCO2 [ Time Frame: Immediately upon study enrollment, an average time of 30 minutes post arrival to the hospital. ] [ Designated as safety issue: No ]
    The EtCO2 level is measured by capnography and compared to the carboxyhemoglobin level.


Estimated Enrollment: 150
Study Start Date: October 2006
Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Carbon Monoxide Exposure

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients presenting to the emergency department at an urban county hospital.

Criteria

Inclusion Criteria:

  • Carbon monoxide exposure

Exclusion Criteria:

  • Less than 18 years old
  • Suicide attempt
  • Unable to provide informed consent
  • Pregnant
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01859156

Contacts
Contact: James R Miner, MD 612-873-8791 research.hcmed@gmail.com

Locations
United States, Minnesota
Hennepin County Medical Center Recruiting
Minneapolis, Minnesota, United States, 55415
Contact: James R Miner, MD    612-873-8791    research.hcmed@gmail.com   
Principal Investigator: James R Miner, MD         
Sponsors and Collaborators
Minneapolis Medical Research Foundation
Investigators
Principal Investigator: James R Miner, MD Minneapolis Medical Research Foundation
  More Information

No publications provided

Responsible Party: Minneapolis Medical Research Foundation
ClinicalTrials.gov Identifier: NCT01859156     History of Changes
Other Study ID Numbers: 06-2713
Study First Received: May 8, 2013
Last Updated: December 19, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Minneapolis Medical Research Foundation:
Carbon Monoxide
Carboxyhemoglobin
End-tidal carbon dioxide
Capnography

Additional relevant MeSH terms:
Carbon Monoxide Poisoning
Gas Poisoning
Poisoning
Substance-Related Disorders
Carbon Monoxide
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 17, 2014